Similar Posts
Rural Voters Elected President Trump. Is He about to Ruin Their Local Hospitals?
ByadminIt’s not an easy time to be a small, rural hospital. Insurance companies aren’t willing to pay generously for your services, given your measly market share. You are increasingly forced to compete against large integrated healthcare systems – conglomerations of urban, suburban and rural providers armed with big marketing budgets and specialized (generously reimbursed!) services….
What Is Maddening about Pharmaceutical Prices?
ByadminImagine that you are gasping for breath, literally on the verge of death. Then someone injects you with a medicine and – miracle! – you are perfectly healthy again. Would you pay $300 for that injection? The treatment is epinephrine; your illness was a life-threatening allergy. And that $300 price? That reflects a six-fold increase…
Outrageous Hospital Expenses
ByadminGetting relatively simple procedures is much more expensive in the US than elsewhere. Take the cost of an appendectomy: Or having a baby: Or having a baby by C-section, a more invasive procedure that is not only more expensive in the US than elsewhere, but is often more common: These prices beg for government regulation!
These Americans Are Rich – Should We Celebrate?
ByadminAmerican manufacturing has declined precipitously in the past few decades. Companies that were once the source of fabulous wealth for Americans – the U.S. Steel profits that enriched the Carnegie family, the Ford Motor F -1.29% Company profits that enriched its eponymous family – are now struggling to keep up with foreign competitors. Thank God…
Is It Rational for Breast Cancer Patients to Have Bilateral Mastectomies?
ByadminWarning: I am not writing about Angelina Jolie. I am not asking whether women like Jolie, with a strong family histories of breast cancer and known genetic mutations, should consider having bilateral mastectomies. Women like Jolie face extremely high lifetime risks of breast cancer, and thus must make difficult decisions about whether to receive prophylactic…
Debate over New FDA Commissioner
ByadminIn a previous post, I argued in favor of Rob Califf as FDA Commissioner. Here is an article from the Duke Chronicle, exploring more of this important debate. Dr. Robert Califf, former vice chancellor of clinical and translational research, may soon be taking helm of the U.S. Food and Drug Administration, but not without resistance from organizations…